These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 21318586)

  • 1. Differentiation-inducing activity of hydroxycamptothecin on cancer stem-like cells derived from hepatocellular carcinoma.
    Zhang Y; Song WJ; Zhang FQ; Liu WH; Dou KF
    Dig Dis Sci; 2011 Aug; 56(8):2473-81. PubMed ID: 21318586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation of human hepatoma Hep G2 cells induced by 10-hydroxycamptothecin.
    Zhang X; Zhou Y; Xu B
    Chin Med J (Engl); 2000 Aug; 113(8):712-3. PubMed ID: 11776054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation-inducing action of 10-hydroxycamptothecin on human hepatoma Hep G2 cells.
    Zhang XW; Jiang JF; Xu B
    Acta Pharmacol Sin; 2000 Apr; 21(4):364-8. PubMed ID: 11324469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of hydroxycamptothecin on apoptosis-inducing factor (AIF) expression and on AIF translocation in human hepatocellular cancer cell SMMC-7721].
    Fu YR; Qiu ZY; Yan YR
    Zhonghua Gan Zang Bing Za Zhi; 2006 Apr; 14(4):285-8. PubMed ID: 16635299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation therapy: sesamin as an effective agent in targeting cancer stem-like side population cells of human gallbladder carcinoma.
    Kong X; Ma MZ; Zhang Y; Weng MZ; Gong W; Guo LQ; Zhang JX; Wang GD; Su Q; Quan ZW; Yang JR
    BMC Complement Altern Med; 2014 Jul; 14():254. PubMed ID: 25038821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ABCG2 inhibitor YHO-13351 sensitizes cancer stem/initiating-like side population cells to irinotecan.
    Shishido Y; Ueno S; Yamazaki R; Nagaoka M; Matsuzaki T
    Anticancer Res; 2013 Apr; 33(4):1379-86. PubMed ID: 23564776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties.
    Chiba T; Kita K; Zheng YW; Yokosuka O; Saisho H; Iwama A; Nakauchi H; Taniguchi H
    Hepatology; 2006 Jul; 44(1):240-51. PubMed ID: 16799977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential regulation of P53, c-Myc, Bcl-2, Bax and AFP protein expression, and caspase activity during 10-hydroxycamptothecin-induced apoptosis in Hep G2 cells.
    Zhang XW; Xu B
    Anticancer Drugs; 2000 Oct; 11(9):747-56. PubMed ID: 11129738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycyrrhetinic Acid and TAT Peptide Modified Dual-functional Liposomes for Treatment of Hepatocellular Cancer.
    Huang S; Ren D; Wu X; Li M; Yu X; Nie X; Wang Y; Wang Y
    Curr Top Med Chem; 2020; 20(27):2493-2505. PubMed ID: 32703132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a stem-like population in hepatocellular carcinoma MHCC97 cells.
    Zhang N; Li R; Tao KS; Cao DY; Ti ZY; Ding R; Cai L; Zhang FQ; Dou KF
    Oncol Rep; 2010 Mar; 23(3):827-31. PubMed ID: 20127026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination treatment with Rhizoma Paridis and Rhizoma Curcuma longa extracts and 10-hydroxycamptothecin enhances the antitumor effect in H22 tumor model by increasing the plasma concentration.
    Liu Z; Li H; Fan Y; Liu Y; Man S; Yu P; Gao W
    Biomed Pharmacother; 2016 Oct; 83():627-634. PubMed ID: 27459119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between lactone ring forms of HCPT and their antitumor activities.
    Zhou JJ; Liu J; Xu B
    Acta Pharmacol Sin; 2001 Sep; 22(9):827-30. PubMed ID: 11749865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiated human colorectal cancer cells protect tumor-initiating cells from irinotecan.
    Emmink BL; Van Houdt WJ; Vries RG; Hoogwater FJ; Govaert KM; Verheem A; Nijkamp MW; Steller EJ; Jimenez CR; Clevers H; Borel Rinkes IH; Kranenburg O
    Gastroenterology; 2011 Jul; 141(1):269-78. PubMed ID: 21459094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNAs involved in neoplastic transformation of liver cancer stem cells.
    Li R; Qian N; Tao K; You N; Wang X; Dou K
    J Exp Clin Cancer Res; 2010 Dec; 29(1):169. PubMed ID: 21176238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of the characteristics of side population cells in the human ovarian cancer cell line OVCAR-3].
    Luo LJ; Zhao Z; Zeng JF; Liang B; Yang JX; Cao DY; Shen K
    Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):281-5. PubMed ID: 22781115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation therapy of hepatocellular carcinoma by inhibiting the activity of AKT/GSK-3β/β-catenin axis and TGF-β induced EMT with sophocarpine.
    Zhang PP; Wang PQ; Qiao CP; Zhang Q; Zhang JP; Chen F; Zhang X; Xie WF; Yuan ZL; Li ZS; Chen YX
    Cancer Lett; 2016 Jun; 376(1):95-103. PubMed ID: 26945965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteopontin promotes a cancer stem cell-like phenotype in hepatocellular carcinoma cells via an integrin-NF-κB-HIF-1α pathway.
    Cao L; Fan X; Jing W; Liang Y; Chen R; Liu Y; Zhu M; Jia R; Wang H; Zhang X; Zhang Y; Zhou X; Zhao J; Guo Y
    Oncotarget; 2015 Mar; 6(9):6627-40. PubMed ID: 25749383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of side population cells in human hepatocellular carcinoma cell lines with stepwise metastatic potentials.
    Shi GM; Xu Y; Fan J; Zhou J; Yang XR; Qiu SJ; Liao Y; Wu WZ; Ji Y; Ke AW; Ding ZB; He YZ; Wu B; Yang GH; Qin WZ; Zhang W; Zhu J; Min ZH; Wu ZQ
    J Cancer Res Clin Oncol; 2008 Nov; 134(11):1155-63. PubMed ID: 18470535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting PRMT5 Activity Inhibits the Malignancy of Hepatocellular Carcinoma by Promoting the Transcription of HNF4α.
    Zheng BN; Ding CH; Chen SJ; Zhu K; Shao J; Feng J; Xu WP; Cai LY; Zhu CP; Duan W; Ding J; Zhang X; Luo C; Xie WF
    Theranostics; 2019; 9(9):2606-2617. PubMed ID: 31131056
    [No Abstract]   [Full Text] [Related]  

  • 20. The transcription factor SALL4 regulates stemness of EpCAM-positive hepatocellular carcinoma.
    Zeng SS; Yamashita T; Kondo M; Nio K; Hayashi T; Hara Y; Nomura Y; Yoshida M; Hayashi T; Oishi N; Ikeda H; Honda M; Kaneko S
    J Hepatol; 2014 Jan; 60(1):127-34. PubMed ID: 24012616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.